Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse.

Iaccarino L, Ottone T, Alfonso V, Cicconi L, Divona M, Lavorgna S, Travaglini S, Ferrantini A, Falconi G, Baer C, Usai M, Forghieri F, Venditti A, Del Principe MI, Arcese W, Voso MT, Haferlach T, Lo-Coco F.

Am J Hematol. 2019 Oct;94(10):1091-1097. doi: 10.1002/ajh.25573. Epub 2019 Jul 23.

PMID:
31292998
2.

Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations.

Mariotti B, Meconi F, Palmieri R, De Bellis E, Lavorgna S, Ottone T, Martini V, Lo-Coco F, Cicconi L.

Case Rep Hematol. 2019 Apr 11;2019:6707506. doi: 10.1155/2019/6707506. eCollection 2019.

3.

STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype.

Ciangola G, Gurnari C, Paterno G, Mirabile M, Angelini M, Lavorgna S, Ottone T, Travaglini S, Cicconi L, LoCoco F.

Leuk Res. 2019 Mar;78:21-23. doi: 10.1016/j.leukres.2019.01.004. Epub 2019 Jan 15. No abstract available.

PMID:
30665050
4.

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia.

Alfonso V, Iaccarino L, Ottone T, Cicconi L, Lavorgna S, Divona M, Cairoli R, Cristiano A, Ciardi C, Travaglini S, Falconi G, Hasan SK, Venditti A, Arcese W, Voso MT, Lo-Coco F.

Leukemia. 2019 Jun;33(6):1527-1530. doi: 10.1038/s41375-018-0298-3. Epub 2019 Jan 16. No abstract available.

PMID:
30651632
5.

A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.

Piedimonte M, Ottone T, Alfonso V, Ferrari A, Conte E, Divona M, Bianchi MP, Ricciardi MR, Mirabilii S, Licchetta R, Campagna A, Cicconi L, Galassi G, Pelliccia S, Leporace A, Lo Coco F, Tafuri A.

BMC Cancer. 2019 Jan 10;19(1):50. doi: 10.1186/s12885-019-5265-5. Review.

6.

Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.

Iaccarino L, Divona M, Ottone T, Cicconi L, Lavorgna S, Ciardi C, Alfonso V, Travaglini S, Facchini L, Cimino G, Di Bona E, Voso MT, Lo-Coco F.

Genes Chromosomes Cancer. 2019 Jan;58(1):60-65. doi: 10.1002/gcc.22708. Epub 2018 Dec 4.

PMID:
30421475
7.

Molecular remission as a therapeutic objective in acute promyelocytic leukemia.

Cicconi L, Fenaux P, Kantarjian H, Tallman M, Sanz MA, Lo-Coco F.

Leukemia. 2018 Aug;32(8):1671-1678. doi: 10.1038/s41375-018-0219-5. Epub 2018 Jul 19. Review.

PMID:
30026570
8.

Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy.

Cicconi L, Breccia M, Franceschini L, Latagliata R, Molica M, Divona M, Diverio D, Rizzo M, Ottone T, Iaccarino L, Alfonso V, Foa R, Voso MT, Lo-Coco F.

Ann Hematol. 2018 Oct;97(10):1797-1802. doi: 10.1007/s00277-018-3400-z. Epub 2018 Jun 27.

PMID:
29951912
9.

Towards home-based treatment for acute promyelocytic leukaemia, with caution.

Lo-Coco F, Cicconi L.

Lancet Oncol. 2018 Jul;19(7):846-847. doi: 10.1016/S1470-2045(18)30355-3. Epub 2018 Jun 5. No abstract available.

PMID:
29884592
10.

Clinical characteristics and treatment outcome of an 86-year-old patient with acute myeloid leukaemia with acute promyelocytic-like morphology and uncommon RARA fusion variant.

Castelli R, Rossi V, Della Porta MG, Schiavon R, Barchiesi M, Cicconi L, Coco FL.

Ann Hematol. 2018 Dec;97(12):2523-2525. doi: 10.1007/s00277-018-3377-7. Epub 2018 Jun 5. No abstract available.

PMID:
29872883
11.

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

Ottone T, Alfonso V, Iaccarino L, Hasan SK, Mancini M, Divona M, Lavorgna S, Cicconi L, Panetta P, Maurillo L, Del Principe MI, Irno Consalvo M, Franceschini L, Angelini DF, Battistini L, Guerrera G, De Bardi M, Fabiani E, Falconi G, Arcese W, Amadori S, Buccisano F, Venditti A, Voso MT, Lo-Coco F.

Am J Hematol. 2018 May;93(5):E120-E123. doi: 10.1002/ajh.25061. Epub 2018 Feb 24. No abstract available.

12.

Progress and criticalities in the management of acute promyelocytic leukemia.

Lo-Coco F, Cicconi L, Voso MT.

Oncotarget. 2017 Nov 12;8(59):99221-99222. doi: 10.18632/oncotarget.22385. eCollection 2017 Nov 21. No abstract available.

13.

The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia.

Fabiani E, Falconi G, Noguera NI, Saulle E, Cicconi L, Divona M, Banella C, Picardi A, Cerio AM, Boe L, Sanchez M, Pelosi E, Testa U, Lo-Coco F, Voso MT.

Oncotarget. 2017 Sep 20;8(48):84074-84085. doi: 10.18632/oncotarget.21101. eCollection 2017 Oct 13.

14.

Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.

Iaccarino L, Ottone T, Hasan SK, Divona M, Cicconi L, Lavorgna S, Alfonso V, Basso G, Barragán E, Bocchia M, Rego EM, Grimwade D, Voso MT, Lo-Coco F.

Leuk Lymphoma. 2018 May;59(5):1268-1270. doi: 10.1080/10428194.2017.1369067. Epub 2017 Aug 24. No abstract available.

PMID:
28838264
15.

Treatment of Low-Blast Count AML using Hypomethylating Agents.

De Bellis E, Fianchi L, Buccisano F, Criscuolo M, Maurillo L, Cicconi L, Brescini M, Del Principe MI, Di Veroli A, Venditti A, Amadori S, Arcese W, Lo-Coco F, Voso MT.

Mediterr J Hematol Infect Dis. 2017 Jul 1;9(1):e2017045. doi: 10.4084/MJHID.2017.045. eCollection 2017. Review.

16.

High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.

Noguera NI, Pelosi E, Angelini DF, Piredda ML, Guerrera G, Piras E, Battistini L, Massai L, Berardi A, Catalano G, Cicconi L, Castelli G, D'Angiò A, Pasquini L, Graziani G, Fioritoni G, Voso MT, Mastrangelo D, Testa U, Lo-Coco F.

Oncotarget. 2017 May 16;8(20):32550-32565. doi: 10.18632/oncotarget.15925.

17.

Clonal evolution in therapy-related neoplasms.

Fabiani E, Falconi G, Fianchi L, Criscuolo M, Ottone T, Cicconi L, Hohaus S, Sica S, Postorino M, Neri A, Lionetti M, Leone G, Lo-Coco F, Voso MT.

Oncotarget. 2017 Feb 14;8(7):12031-12040. doi: 10.18632/oncotarget.14509.

18.

Identification of a potential topoisomerase II "hotspot" DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms.

Piredda ML, Catalano G, Ciardi C, Divona M, Cicconi L, Panetta P, Curzi P, Garza E, Martínez-Losada C, Postorino M, Lo-Coco F, Noguera NI.

Ann Hematol. 2017 Jan;96(1):155-157. doi: 10.1007/s00277-016-2843-3. Epub 2016 Oct 13. No abstract available.

PMID:
27734129
19.

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, Ferrara F, Divona M, Albano F, Efficace F, Fazi P, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Wattad M, Lübbert M, Brandts CH, Hänel M, Röllig C, Schmitz N, Link H, Frairia C, Pogliani EM, Fozza C, D'Arco AM, Di Renzo N, Cortelezzi A, Fabbiano F, Döhner K, Ganser A, Döhner H, Amadori S, Mandelli F, Ehninger G, Schlenk RF, Lo-Coco F.

J Clin Oncol. 2017 Feb 20;35(6):605-612. doi: 10.1200/JCO.2016.67.1982. Epub 2016 Oct 31.

20.

Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial.

Delaney C, Milano F, Cicconi L, Othus M, Becker PS, Sandhu V, Nicoud I, Dahlberg A, Bernstein ID, Appelbaum FR, Estey EH.

Lancet Haematol. 2016 Jul;3(7):e330-9. doi: 10.1016/S2352-3026(16)30023-0. Epub 2016 Jun 7.

PMID:
27374466
21.

PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.

Cicconi L, Divona M, Ciardi C, Ottone T, Ferrantini A, Lavorgna S, Alfonso V, Paoloni F, Piciocchi A, Avvisati G, Ferrara F, Di Bona E, Albano F, Breccia M, Cerqui E, Sborgia M, Kropp MG, Santoro A, Levis A, Sica S, Amadori S, Voso MT, Mandelli F, Lo-Coco F.

Leukemia. 2016 Oct;30(10):1987-1992. doi: 10.1038/leu.2016.122. Epub 2016 May 2.

PMID:
27133819
22.

Current management of newly diagnosed acute promyelocytic leukemia.

Cicconi L, Lo-Coco F.

Ann Oncol. 2016 Aug;27(8):1474-81. doi: 10.1093/annonc/mdw171. Epub 2016 Apr 15. Review.

PMID:
27084953
23.

Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia.

Iaccarino L, Ottone T, Divona M, Cicconi L, Cairoli R, Voso MT, Lo-Coco F.

Br J Haematol. 2016 Mar;172(6):909-13. doi: 10.1111/bjh.13910. Epub 2016 Jan 5. Erratum in: Br J Haematol. 2016 Jul;174(2):335.

PMID:
26728337
24.

Current standard treatment of adult acute promyelocytic leukaemia.

Lo-Coco F, Cicconi L, Breccia M.

Br J Haematol. 2016 Mar;172(6):841-54. doi: 10.1111/bjh.13890. Epub 2015 Dec 21. Review.

PMID:
26687281
25.

Outpatient oral treatment for acute promyelocytic leukemia.

Lo-Coco F, Cicconi L.

N Engl J Med. 2015 Feb 26;372(9):884-5. doi: 10.1056/NEJMc1500125. No abstract available.

PMID:
25714181
26.

Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis.

Rago A, Latagliata R, Montanaro M, Montefusco E, Andriani A, Crescenzi SL, Mecarocci S, Spirito F, Spadea A, Recine U, Cicconi L, Avvisati G, Cedrone M, Breccia M, Porrini R, Villivà N, De Gregoris C, Alimena G, D'Arcangelo E, Guglielmelli P, Lo-Coco F, Vannucchi A, Cimino G.

Leuk Res. 2015 Mar;39(3):314-7. doi: 10.1016/j.leukres.2015.01.001. Epub 2015 Jan 12.

PMID:
25636356
27.

Retinoic acid receptors: from molecular mechanisms to cancer therapy.

di Masi A, Leboffe L, De Marinis E, Pagano F, Cicconi L, Rochette-Egly C, Lo-Coco F, Ascenzi P, Nervi C.

Mol Aspects Med. 2015 Feb;41:1-115. doi: 10.1016/j.mam.2014.12.003. Epub 2014 Dec 25.

PMID:
25543955
28.

A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes.

Cattaneo M, Pelosi E, Castelli G, Cerio AM, D'Angiò A, Porretti L, Rebulla P, Pavesi L, Russo G, Giordano A, Turri J, Cicconi L, Lo-Coco F, Testa U, Biunno I.

J Cell Physiol. 2015 Aug;230(8):1770-80. doi: 10.1002/jcp.24876.

PMID:
25502508
29.

What is the standard regimen for patients with acute promyelocytic leukemia?

Lo-Coco F, Cicconi L.

Curr Hematol Malig Rep. 2014 Jun;9(2):138-43. doi: 10.1007/s11899-014-0206-5. Review.

PMID:
24729066
30.

ATRA + ATO: has a new standard of care been established in low-risk acute promyelocytic leukaemia?

Breccia M, Cicconi L, Lo-Coco F.

Curr Opin Hematol. 2014 Mar;21(2):95-101. doi: 10.1097/MOH.0000000000000023. Review.

PMID:
24434605
31.

Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23).

Hasan SK, Barba G, Metzler M, Divona M, Ottone T, Cicconi L, Falini B, Mecucci C, Lo-Coco F.

Genes Chromosomes Cancer. 2014 Mar;53(3):248-54. doi: 10.1002/gcc.22135. Epub 2013 Dec 5.

PMID:
24310817
32.

Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge.

Di Veroli A, Micarelli A, Cefalo M, Ceresoli E, Nasso D, Cicconi L, Mauramati S, Ottaviani F, Venditti A, Amadori S.

Case Rep Hematol. 2013;2013:245395. doi: 10.1155/2013/245395. Epub 2013 Sep 12.

33.

Validation of a new proposed relapse risk score (CBC-score) for acute promyelocytic leukaemia.

Loglisci G, Minotti C, Serrao A, Molica M, Cicconi L, Saracino R, Breccia M.

Int J Hematol. 2014 Jan;99(1):100-1. doi: 10.1007/s12185-013-1438-1. Epub 2013 Sep 15. No abstract available.

PMID:
24037456
34.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona E, Specchia G, Sica S, Divona M, Levis A, Fiedler W, Cerqui E, Breccia M, Fioritoni G, Salih HR, Cazzola M, Melillo L, Carella AM, Brandts CH, Morra E, von Lilienfeld-Toal M, Hertenstein B, Wattad M, Lübbert M, Hänel M, Schmitz N, Link H, Kropp MG, Rambaldi A, La Nasa G, Luppi M, Ciceri F, Finizio O, Venditti A, Fabbiano F, Döhner K, Sauer M, Ganser A, Amadori S, Mandelli F, Döhner H, Ehninger G, Schlenk RF, Platzbecker U; Gruppo Italiano Malattie Ematologiche dell'Adulto; German-Austrian Acute Myeloid Leukemia Study Group; Study Alliance Leukemia.

N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.

35.

Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy.

Sarlo C, Buccisano F, Maurillo L, Cefalo M, Di Caprio L, Cicconi L, Ditto C, Ottaviani L, Di Veroli A, Del Principe MI, Grasso MA, Nasso D, De Santis G, Amadori S, Venditti A.

Leuk Res Treatment. 2013;2013:705714. doi: 10.1155/2013/705714. Epub 2013 Apr 28.

36.

Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin.

Ottone T, Zaza S, Divona M, Hasan SK, Lavorgna S, Laterza S, Cicconi L, Panetta P, Di Giandomenico J, Cittadini M, Ciardi C, Montefusco E, Franchi A, Annino L, Venditti A, Amadori S, Lo-Coco F.

Br J Haematol. 2013 May;161(4):533-40. doi: 10.1111/bjh.12288. Epub 2013 Mar 11.

PMID:
23480665
37.

Thoracic cord compression caused by epidural extramedullary hematopoiesis during erythroid-stimulating agent therapy in two patients with myelodysplastic syndromes.

Buccisano F, Maurillo L, Neri B, Masala S, Mauriello A, Del Principe MI, Ditto C, Sarlo C, Cefalo M, Di Caprio L, Loreni G, Cicconi L, Amadori S, Venditti A.

J Clin Oncol. 2013 Apr 10;31(11):e189-91. doi: 10.1200/JCO.2012.45.3209. Epub 2013 Feb 19. No abstract available.

PMID:
23423741
38.

Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia.

Gaur GC, Ramadan SM, Cicconi L, Noguera NI, Luna I, Such E, Lavorgna S, Di Giandomenico J, Sanz MA, Lo-Coco F.

Ann Hematol. 2012 Dec;91(12):1855-60. doi: 10.1007/s00277-012-1546-7. Epub 2012 Aug 16.

PMID:
22895555
39.

Novel strategies in treatment of acute promyelocytic leukemia.

Lo-Coco F, Cicconi L.

Leuk Suppl. 2012 Aug;1(Suppl 2):S18-9. doi: 10.1038/leusup.2012.12. Epub 2012 Aug 9.

40.

History of acute promyelocytic leukemia: a tale of endless revolution.

Lo-Coco F, Cicconi L.

Mediterr J Hematol Infect Dis. 2011;3(1):e2011067. doi: 10.4084/MJHID.2011.067. Epub 2011 Dec 21. No abstract available.

41.

Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia.

Ottone T, Cicconi L, Hasan SK, Lavorgna S, Divona M, Voso MT, Montefusco E, Melillo L, Barragán E, Platzbecker U, Giannì L, Hubmann M, Pagoni M, Amadori S, Lo-Coco F.

Leuk Res. 2012 Apr;36(4):474-8. doi: 10.1016/j.leukres.2011.10.015. Epub 2011 Nov 8.

PMID:
22071137
42.

Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia.

Breccia M, Cicconi L, Minotti C, Latagliata R, Giannì L, Lo-Coco F.

Haematologica. 2011 Sep;96(9):1390-1. doi: 10.3324/haematol.2011.045500. Epub 2011 Jun 9. No abstract available.

43.

Transient ischemic attack as initial manifestation of acute promyelocytic leukemia.

Cicconi L, Madeo G, Ramadan SM, Forte V, Mercuri N, Lo-Coco F.

Leuk Res. 2011 Jul;35(7):e134-5. doi: 10.1016/j.leukres.2011.03.008. Epub 2011 Apr 5. No abstract available.

PMID:
21470679
44.

Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.

Hasan SK, Buttari F, Ottone T, Voso MT, Hohaus S, Marasco E, Mantovani V, Garagnani P, Sanz MA, Cicconi L, Bernardi G, Centonze D, Lo-Coco F.

Neurology. 2011 Mar 22;76(12):1059-65. doi: 10.1212/WNL.0b013e318211c3c8. Epub 2011 Feb 23.

PMID:
21346221
45.

Long-term seventh molecular remission in acute promyelocytic leukaemia.

Cicconi L, Romano A, Ramadan SM, Divona M, Petti MC, Lo-Coco F.

Ann Hematol. 2011 Nov;90(11):1369-70. doi: 10.1007/s00277-011-1189-0. Epub 2011 Feb 19. No abstract available.

PMID:
21336626
46.

Prevention of transmissible infections in the perioperative setting.

Cicconi L, Claypool M, Stevens W.

AORN J. 2010 Nov;92(5):519-27. doi: 10.1016/j.aorn.2010.06.016.

PMID:
21040816
47.

Molecular characterization of paediatric idiopathic hypereosinophilia.

Rapanotti MC, Caruso R, Ammatuna E, Zaza S, Trotta L, Divona M, Cicconi L, Funaro D, Federici G, Amadori S, De Rossi G, Lo-Coco F.

Br J Haematol. 2010 Dec;151(5):440-6. doi: 10.1111/j.1365-2141.2010.08394.x. Epub 2010 Oct 19.

PMID:
20955401

Supplemental Content

Loading ...
Support Center